2023 Annual Meeting Poster Awardee Spotlight
Time: 8AM PST | 11AM EST | 5PM CET Date: February 29, 2024 Title: Towards Allele-Selective Gapmer ASO Design Description:Â Allele selective gapmer antisense oligonucleotides (ASOs) are a promising strategy for the treatment of rare monogenic neurodevelopmental disorders caused by gain-of-function or ...
Meet OTS’ New BOD Trainee Reps
Time: 8AM PST | 11AM EST | 5PM CET Date: February 22, 2024 Title: Advancing Therapeutic Approaches for Erythropoietic Protoporphyria Description: Currently, no curative treatment is available for the rare disease erythropoietic protoporphyria (EPP). The genetic background of EPP is well ...
2023 Annual Meeting Poster Awardee Spotlight
Time: 8AM PST | 11AM EST | 5PM CET Date: January 25, 2024 Title: siRNA therapy for ex vivo treatment of stem cell grafts and/or donor lymphocytes Description: Allogeneic T cells represent the most potent treatment for hematopoietic malignancies such es ...
Non-viral DNA delivery: Opportunities and challenges
Time: 8AM PST | 11AM EST | 5PM CET Date: October 12, 2023 This presentation will cover defining the key hurdles for non-viral DNA delivery, innate immune stimulation, and delivery to post-mitotic nuclei, as well as strategies to address these challenges. ...
ASO activity and distribution after LNP delivery
Time: 8AM PST | 11AM EST | 5PM CET Date: Thursday, September 14, 2023 Webinar title: Assessing antisense oligonucleotide delivery to the brain What is your research about? Amy Byrnes, PhD, focuses her research on understanding how delivery vehicles impact antisense oligonucleotide (ASO) ...
Muscle targeted siRNA Conjugates for Pompe Disease
Time: 8AM PST / 11AM EST / 5PM CET Date: August 3, 2023 Aro Biotx is focused on developing Centyrin-siRNA conjugates for treatment of extrahepatic genetic diseases. Our lead program employs a CD71 Centyrin for targeting to muscle together with an siRNA for ...
Developing Oligonucleotides Into Therapies: Opportunities and Challenges
Time: 8AM PST / 11AM EST / 5PM CET Date: July 6, 2023 Speakers: Shalini Andersson, PhD Vice President of Oligonucleotide Discovery AstraZeneca View Bio
Pathways for patient-centered interventional genomic medicine
Time: 8AM PST | 11AM EST | 5PM CET Date: June 22, 2023 Speakers: Timothy Yu, PhD, MD Neurogeneticist Boston Children’s Hospital and Harvard Medical School View Bio
Introduction to Nucleic Acid Immunity, and It’s Implications For Optimizing Cancer Immunotherapy
Time: 8AM PST | 11AM EST | 5PM CET Date: June 8, 2023 Starting from the concept and principles of Nucleic Acid Immunity, I will explain why TLR7 and TLR9 are unique among the nucleic acid immune sensing receptors for their ability to ...
Trainee Spotlight Series: Remko Goossens & Priyanka Shukla
Time: 8AM Pacific | 11AM Eastern | 5PM CET Date: May 18, 2023 Speakers: Remko Goossens Leiden University Medical Center Remko will outline our findings concerning the relationship between the splicing speed of ...